Activation	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
through	O
reactive	O
oxygen	O
species	O
mediates	O
20	O
-	O
hydroxyeicosatetraenoic	O
acid	O
-	O
induced	O
endothelial	B-Cell
cell	I-Cell
proliferation	O
.	O

20	O
-	O
Hydroxyeicosatetraenoic	O
acid	O
(	O
20	O
-	O
HETE	O
)	O
is	O
formed	O
by	O
the	O
omega	O
-	O
hydroxylation	O
of	O
arachidonic	O
acid	O
by	O
cytochrome	O
P450	O
4A	O
and	O
4F	O
enzymes	O
,	O
and	O
it	O
induces	O
angiogenic	O
responses	O
in	O
vivo	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
20	O
-	O
HETE	O
increases	O
endothelial	B-Cell
cell	I-Cell
(	O
EC	B-Cell
)	O
proliferation	O
via	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
,	O
we	O
studied	O
the	O
effects	O
of	O
WIT003	O
[	O
20	O
-	O
hydroxyeicosa	O
-	O
5	O
(	O
Z	O
)	O
,	O
14	O
(	O
Z	O
)	O
-	O
dienoic	O
acid	O
]	O
,	O
a	O
20	O
-	O
HETE	O
analog	O
on	O
human	O
macrovascular	B-Cell
or	O
microvascular	B-Cell
EC	I-Cell
.	O

WIT003	O
,	O
as	O
well	O
as	O
pure	O
20	O
-	O
HETE	O
,	O
stimulated	O
EC	B-Cell
proliferation	O
by	O
approximately	O
40	O
%	O
.	O

These	O
proliferative	O
effects	O
were	O
accompanied	O
by	O
increased	O
VEGF	O
expression	O
and	O
release	O
that	O
were	O
observed	O
as	O
early	O
as	O
4	O
h	O
after	O
20	O
-	O
HETE	O
agonist	O
addition	O
.	O

This	O
was	O
accompanied	O
by	O
increased	O
phosphorylation	O
of	O
the	O
VEGF	O
receptor	O
2	O
.	O

The	O
proliferative	O
effects	O
of	O
20	O
-	O
HETE	O
were	O
markedly	O
inhibited	O
by	O
a	O
VEGF	O
-	O
neutralizing	O
antibody	O
.	O

Polyethylene	O
glycol	O
-	O
superoxide	O
dismutase	O
(	O
PEG	O
-	O
SOD	O
)	O
markedly	O
inhibited	O
both	O
the	O
increases	O
in	O
VEGF	O
expression	O
and	O
the	O
proliferative	O
effects	O
of	O
20	O
-	O
HETE	O
.	O

In	O
contrast	O
,	O
administration	O
of	O
the	O
NAD	O
(	O
P	O
)	O
H	O
oxidase	O
inhibitor	O
apocynin	O
had	O
no	O
effect	O
to	O
the	O
proliferative	O
response	O
to	O
20	O
-	O
HETE	O
.	O

The	O
20	O
-	O
HETE	O
agonist	O
markedly	O
increased	O
superoxide	O
formation	O
as	O
reflected	O
by	O
an	O
increase	O
in	O
dihydroethidium	O
staining	O
of	O
EC	B-Cell
,	O
and	O
this	O
increase	O
was	O
inhibited	O
by	O
PEG	O
-	O
SOD	O
but	O
not	O
by	O
apocynin	O
.	O

20	O
-	O
HETE	O
also	O
increased	O
the	O
phosphorylation	O
of	O
p42	O
/	O
p44	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
in	O
EC	B-Cell
,	O
whereas	O
an	O
inhibitor	O
of	O
MAPK	O
[	O
U0126	O
,	O
1	O
,	O
4	O
-	O
diamino	O
-	O
2	O
,	O
3	O
-	O
dicyano	O
-	O
1	O
,	O
4	O
-	O
bis	O
(	O
2	O
-	O
aminophenylthio	O
)	O
butadiene	O
]	O
suppressed	O
the	O
proliferative	O
and	O
the	O
VEGF	O
changes	O
but	O
not	O
the	O
pro	O
-	O
oxidant	O
effects	O
of	O
20	O
-	O
HETE	O
.	O

These	O
data	O
suggest	O
that	O
20	O
-	O
HETE	O
stimulates	O
superoxide	O
formation	O
by	O
pathways	O
other	O
than	O
apocynin	O
-	O
sensitive	O
NAD	O
(	O
P	O
)	O
H	O
oxidase	O
,	O
thereby	O
activating	O
MAPK	O
and	O
then	O
enhancing	O
VEGF	O
synthesis	O
that	O
drives	O
EC	B-Cell
proliferation	O
.	O

Thus	O
,	O
20	O
-	O
HETE	O
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
EC	B-Cell
functions	O
,	O
such	O
as	O
angiogenesis	O
.	O

